Emerging therapeutic strategies

Oral cavity and oropharyngeal carcinomas represents a significant cause of morbidity and mortality. In spite of endeavors in improving early finding and treatment, the 5-year endurance pace of cutting edge phase of the illness is under 63%.The field of nanomedicine has offered promising diagnostic and therapeutic advances in cancer. Without a doubt, a few stages have been clinically affirmed for disease treatment, while other promising frameworks are experiencing investigation in clinical preliminaries.With its ability to deliver drugs, nucleic acids, and MRI contrast agents with high efficiency, nanomedicine platforms offer the potential to improve drug efficacy and tolerability. The point of the present smaller than expected audit is to abridge the current preclinical status of nanotechnology frameworks for oral malignant growth treatment.

  • Cancer Nanotechnology
  • Cancer Pharmocology

Related Conference of Emerging therapeutic strategies

March 10-11, 2025

3rd World Congress on Oral Cancer

Paris, France
March 24-25, 2025

25th World Congress on Cancer and Diagnostics

London, UK
March 24-25, 2025

10th World Conference on Breast and Cervical Cancer

Paris, France
April 07-08, 2025

15th World Congress on Breast Cancer

Vancouver, Canada
April 28-29, 2025

35th Experts Meet On Cancer Research & Therapy

Aix-en-Provence, France
June 16-17, 2025

26th World Congress on Cancer Summit

Amsterdam, Netherlands
July 14-15, 2025

5th World Congress on Breast Cancer

Berlin, Germany
July 28-29, 2025

45th Euro Congress on Cancer Science & Therapy

Aix-en-Provence, France
October 20-21, 2025

21st International Conference on Cancer Research

Barcelona, Spain

Emerging therapeutic strategies Conference Speakers

    Recommended Sessions

    Related Journals

    Are you interested in